Compare AMRX & RH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | RH |
|---|---|---|
| Founded | 2002 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.2B |
| IPO Year | N/A | 1998 |
| Metric | AMRX | RH |
|---|---|---|
| Price | $13.34 | $208.70 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 16 |
| Target Price | $13.25 | ★ $227.33 |
| AVG Volume (30 Days) | ★ 1.7M | 1.3M |
| Earning Date | 10-30-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.11 |
| EPS | 0.02 | ★ 5.52 |
| Revenue | $2,934,959,000.00 | ★ $3,409,319,000.00 |
| Revenue This Year | $9.99 | $12.43 |
| Revenue Next Year | $6.67 | $8.89 |
| P/E Ratio | $807.28 | ★ $38.07 |
| Revenue Growth | 9.50 | ★ 9.74 |
| 52 Week Low | $6.69 | $123.03 |
| 52 Week High | $13.25 | $455.84 |
| Indicator | AMRX | RH |
|---|---|---|
| Relative Strength Index (RSI) | 68.90 | 72.76 |
| Support Level | $12.33 | $178.61 |
| Resistance Level | $12.99 | $189.68 |
| Average True Range (ATR) | 0.30 | 9.13 |
| MACD | 0.00 | 3.43 |
| Stochastic Oscillator | 92.28 | 79.44 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
RH is a luxury furniture and lifestyle retailer operating in the $136 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories including furniture, lighting, textiles, bath, decor, and children and is growing the presence of its hospitality business with 23 restaurant locations, including RH Guesthouse. RH innovates, curates, and integrates products, categories, services, and businesses across channels and brand extensions (RH Modern and Waterworks, for example). RH is fully integrated across channels and is positioned to broaden its addressable market over the next decade via expanding abroad, its World of RH digital platform (highlighting offerings outside of home furnishings), and offerings in architecture, media, and more.